Affiliation:
1. From the Second Department of Internal Medicine, Faculty of Medicine, University of Tokyo (T.N., K.I., H.O., H.I., H.H., M.A., T.M., F.N., J.S., M.O.), and the Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba (S.S., Y.K., Y.O.), Ibaraki, Japan.
Abstract
Background
—It has been suggested that intracellular Ca
2+
overload in cardiac myocytes leads to the development of diabetic cardiomyopathy. Troglitazone, an insulin-sensitizing agent, is a promising therapeutic agent for diabetes and has been shown to prevent diabetes-induced myocardial changes. To elucidate the underlying mechanism of troglitazone action on cardiac myocytes, the effects of troglitazone on voltage-dependent Ca
2+
currents were examined and compared with classic Ca
2+
antagonists (verapamil and nifedipine).
Methods and Results
—Whole-cell voltage-clamp techniques were applied in single guinea pig atrial myocytes. Under control conditions with CsCl internal solution, the voltage-dependent Ca
2+
currents consisted of both T-type (
I
Ca,T
) and L-type (
I
Ca,L
) Ca
2+
currents. Troglitazone effectively reduced the amplitude of
I
Ca,L
in a concentration-dependent manner. Troglitazone also suppressed
I
Ca,T
, but the effect of troglitazone on
I
Ca,T
was less potent than that on
I
Ca,L
. The current-voltage relationships for
I
Ca,L
and the reversal potential for
I
Ca,L
were not altered by troglitazone. The half-maximal inhibitory concentration of troglitazone on
I
Ca,L
measured at a holding potential of −40 mV was 6.3 μmol/L, and 30 μmol/L troglitazone almost completely inhibited
I
Ca,L
. Troglitazone 10 μmol/L did not affect the time courses for inactivation of
I
Ca,L
and inhibited
I
Ca,L
mainly in a use-independent fashion, without shifting the voltage-dependency of inactivation. This effect was different from those of verapamil and nifedipine. Troglitazone also reduced isoproterenol- or cAMP-enhanced
I
Ca,L
.
Conclusions
—These results demonstrate that troglitazone inhibits voltage-dependent Ca
2+
currents (T-type and L-type) and then antagonizes the effects of isoproterenol in cardiac myocytes, thus possibly playing a role in preventing diabetes-induced intracellular Ca
2+
overload and subsequent myocardial changes.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献